Tsoi, H.; Shi, L.; Leung, M.-H.; Man, E.P.S.; So, Z.-Q.; Chan, W.-L.; Khoo, U.-S.
Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast Cancer. Life 2022, 12, 93.
https://doi.org/10.3390/life12010093
AMA Style
Tsoi H, Shi L, Leung M-H, Man EPS, So Z-Q, Chan W-L, Khoo U-S.
Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast Cancer. Life. 2022; 12(1):93.
https://doi.org/10.3390/life12010093
Chicago/Turabian Style
Tsoi, Ho, Ling Shi, Man-Hong Leung, Ellen P. S. Man, Zi-Qing So, Wing-Lok Chan, and Ui-Soon Khoo.
2022. "Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast Cancer" Life 12, no. 1: 93.
https://doi.org/10.3390/life12010093
APA Style
Tsoi, H., Shi, L., Leung, M.-H., Man, E. P. S., So, Z.-Q., Chan, W.-L., & Khoo, U.-S.
(2022). Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast Cancer. Life, 12(1), 93.
https://doi.org/10.3390/life12010093